| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/24/2007 | CN1902352A Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 01/24/2007 | CN1902307A Tissue regeneration method |
| 01/24/2007 | CN1902176A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 01/24/2007 | CN1901939A Treatment of proliferative diseases using an antisense IAP oligomer and chemotherapeutic agent |
| 01/24/2007 | CN1901938A Combination of a DPP-IV inhibitor and an anti-obesity or appetite regulating agent |
| 01/24/2007 | CN1901929A Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent |
| 01/24/2007 | CN1901903A Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders |
| 01/24/2007 | CN1901896A Use of selected amino acid-zinc complexes as anti-malarials |
| 01/24/2007 | CN1901892A Treating infectious diseases using ice inhibitors |
| 01/24/2007 | CN1901863A Methods and reagents for the treatment of inflammatory disorders |
| 01/24/2007 | CN1900104A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
| 01/24/2007 | CN1900079A New imidazole derivative, method for producing the same and use of the same |
| 01/24/2007 | CN1899616A New use of non-receptor tyrosine kinase c-Ab1 specific inhibitor |
| 01/24/2007 | CN1899615A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899614A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899607A Double effect tumor cell vaccine and its preparing method |
| 01/24/2007 | CN1899265A Medical dust cloud agent or granular agent and its use |
| 01/24/2007 | CN1296477C Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1296053C Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 01/24/2007 | CN1296043C Use of formula I Rapamycin compound in preparing pharmaceutical composition for treating solid tumor |
| 01/23/2007 | US7167801 Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates |
| 01/23/2007 | US7166641 Diclofenac salt of lidocaine |
| 01/23/2007 | US7166640 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166612 Methods for reducing platelet activation platelet aggregaton or thrombosis |
| 01/23/2007 | US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166581 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 01/23/2007 | US7166579 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 01/23/2007 | US7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement |
| 01/23/2007 | US7166472 Adding a reducible redox-active metal to a first and a second target protein sample of an auto-oxidizing kynurenine pathway metabolite; incubating to allow cross-linking of target protein, comparing the amounnt of target protein cross-linking |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166309 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof |
| 01/23/2007 | US7166302 Complexing agents for compositions containing inclusion complexes |
| 01/23/2007 | US7166299 Comprises ursodeoxycholic acid for treating gastritis and peptic ulcer disease |
| 01/23/2007 | US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers |
| 01/23/2007 | US7166285 Anti-IL-12 antibodies and compositions |
| 01/23/2007 | US7166283 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 01/23/2007 | US7166281 Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings |
| 01/23/2007 | CA2348086C Controlled-release pharmaceutical formulations |
| 01/23/2007 | CA2345466C Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| 01/23/2007 | CA2101104C Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumors |
| 01/18/2007 | WO2007008665A1 Composition and the use thereof for the treatment of viral infections |
| 01/18/2007 | WO2007007909A1 Combination drug containing diaryl-substituted 5-membered heterocyclic derivative |
| 01/18/2007 | WO2007007757A1 Pharmaceutical composition containing pparϝ agonist |
| 01/18/2007 | WO2007007737A1 Agent for prevention or treatment of glaucoma |
| 01/18/2007 | WO2007006799A1 Use of sertraline in combination with an alkaloid for treating cancer |
| 01/18/2007 | WO2006124689A3 Combination therapy |
| 01/18/2007 | WO2006088748A3 Method for treating obesity |
| 01/18/2007 | WO2005107470A3 Use of carbonic anhydrase inhibitors for insect control and malaria treatment |
| 01/18/2007 | WO2005097192A9 Active substance combination of a carbinol compound and an opioid |
| 01/18/2007 | WO2005069957A3 Unicondylar knee implant |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | WO2004054510A3 Method for identifying modulators of human orexin-2 receptor |
| 01/18/2007 | US20070016074 Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/18/2007 | US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/18/2007 | US20070015780 Method of treating cancer with azaspirane compositions |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015747 Respiratory syncytial virus replication inhibitors |
| 01/18/2007 | US20070015718 Diagnosis and management of infection caused by Chlamydia |
| 01/18/2007 | US20070015714 Methods for treating FSH related conditions with GnRH antagonists |
| 01/18/2007 | US20070015687 Synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 01/18/2007 | US20070015269 Crystals of DPP-IV |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070014876 Synergistic compositions and method for potentiating anti-oxidative activity |
| 01/18/2007 | US20070014861 Treatment of proctitis |
| 01/18/2007 | US20070014860 Treatment of esophagitis |
| 01/18/2007 | US20070014849 Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 01/18/2007 | US20070014837 System and method for use of agent in combination with subatmospheric pressure tissue treatment |
| 01/18/2007 | US20070014816 such as a botulinum toxin; pain is not associated with a headache pain |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014767 TGFbeta1-inhibitor peptides |
| 01/18/2007 | US20070014737 Administering quinine, chlorzoxazone, cyclobenzaprine, carisoprodol via vaporization |
| 01/18/2007 | CA2615118A1 Pharmaceutical composition containing ppar.gamma. agonist |
| 01/18/2007 | CA2614834A1 Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist |
| 01/17/2007 | EP1743944A1 Novel method of screening |
| 01/17/2007 | EP1743903A2 Methods and compositions for treating disorders involving excitotoxicity |
| 01/17/2007 | EP1743656A2 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
| 01/17/2007 | EP1743655A1 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/17/2007 | EP1743654A1 Use of inhibitors of histone deacetylases in combination with NSAID for the therapy of cancer and/or inflammatory diseases |
| 01/17/2007 | EP1743653A1 Composition for increasing body height |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743635A2 Gibberellins for the promotion of ulcer healing |
| 01/17/2007 | EP1742966A2 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 01/17/2007 | EP1742965A2 Treatments for pancreatic cancer |
| 01/17/2007 | EP1742662A2 Combination of prostaglandin e2 receptor antagonists and renin-angiotensin system inhibitors for treating renal diseases |
| 01/17/2007 | EP1742661A2 Lipid compositions and use thereof |
| 01/17/2007 | EP1742645A1 Compressed pharmaceutical compositions comprising peg and electrolytes |
| 01/17/2007 | EP1742638A1 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye |
| 01/17/2007 | EP1742636A2 Preparation for the treatment cancer |
| 01/17/2007 | EP1742630A2 Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
| 01/17/2007 | EP1742629A2 Methods for treating alcoholism |
| 01/17/2007 | EP1742624A2 Dopamine-agonist combination therapy with sedatives for improving sleep quality |
| 01/17/2007 | EP1719524A9 Nuclear transfer promoter for rac protein and method of screening the same |
| 01/17/2007 | EP1546369A4 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |